High-dose vitamin D3 during intensive-phase antimicrobial treatment of pulmonary tuberculosis: a double-blind randomised controlled trial

Adrian R. Martineau(Queen Mary University of London), Peter Timms(Homerton University Hospital NHS Foundation Trust), Graham Bothamley(Homerton University Hospital NHS Foundation Trust), Yasmeen Hanifa(Queen Mary University of London), Kamrul Islam(Queen Mary University of London), Alleyna Claxton(Homerton University Hospital NHS Foundation Trust), Geoffrey E. Packe(London Chest Hospital), J Moore-Gillon(Royal London Hospital), Mathina Darmalingam(Whipps Cross University Hospital), Robert N. Davidson(Northwick Park Hospital), Heather Milburn(Guy's and St Thomas' NHS Foundation Trust), Lucy Baker(University Hospital Lewisham), Richard D. Barker(King's College Hospital), Nicholas Woodward(The Royal Free Hospital), Timothy R Venton(Homerton University Hospital NHS Foundation Trust), Korina E. Barnes(Homerton University Hospital NHS Foundation Trust), Christopher J Mullett(Homerton University Hospital NHS Foundation Trust), Anna K. Coussens, Clare Rutterford(Queen Mary University of London), Charles A. Mein(Queen Mary University of London), Geraint Davies(University of Liverpool), Robert J. Wilkinson, Vladyslav Nikolayevskyy(Barts Health NHS Trust), Francis Drobniewski(Barts Health NHS Trust), Sandra Eldridge(Queen Mary University of London), Chris Griffiths(Queen Mary University of London)
The Lancet
January 1, 2011
Cited by 576

Abstract


Related Papers

No related papers found

Powered by citation graph analysis